Replies to post #167349 on NorthWest Biotherapeutics Inc (NWBO)

[Virgilio]

Obviously unless I missed them and someone wants to update on that.

[exwannabe]

1) OS numbers reached or not and when exatcly?

I would expect Dr B at ASCO to announce that as of <spring> 233 OS had been reached and the company is evaluating when to un-blind the trial or some such. They will not tell you when, just like he never said when 231 OS events were reached.

2) Updates on Direct?

As announced last year, a peer reviewed paper is in process. Per this board, that means they can not talk about Direct at all. Maybe he will announce the number of authors.

3) Updates on the SEC matters?

To be provided Mon or Tue evening.

4) Updates on combo trials?

Watch the clinical trial registries. Muinz has never been seen and UCLA's has been delayed 3 times already from the initial April '17 start. June is the current estimate. No news on when they receive the large payment from BMY that allows them to avoid further dilution.